Global Genome Sequencing Market, By Product (Consumables, Systems and Software, Services), Technology (PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, Others), Application (Diagnostics, Drug Discovery and Development, Precision Medicine, Agriculture and Animal Research, Others), End-User (Research Centers, Academic and Government Institutes, Hospitals & Clinics, Pharmaceutical and Biotechnology Companies, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The genome sequencing market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 15.73% in the forecast period of 2021 to 2028 and is estimated to reach 41,151.61 USD million by 2028. The growing of the prevalence of the cancer will help in escalating the growth of the genome sequencing market.
Genome sequencing is the procedure of mapping and sequencing of the unique DNA of a person. Genome signifies the entire blueprint of a person’s human body. Genome sequencing aids to identify any important differences in the genes, which are a bundle of DNA, in a person’s body which can cause a disease or upsurge the likelihood of a disease.
Major factors that are expected to boost the genome sequencing market in the forecast period are the growing of the government funding to encourage genomics projects, the increasing of the incidence of the cancer and the increasing applications of next-generation sequencing in cancer research. Furthermore, the entry of the new key players and start-ups and the growing application areas of genome sequencing are further anticipated to propel the growth of the genome sequencing market. However, the rise in the cost of the genomic equipment, shortage of skilled professionals and the secure storage of large volumes of sequenced data are few of the factors further estimated to impede the growth of the genome sequencing market in the timeline period. Additionally, the utilization of genomics in specialized or personalized medicine will further provide opportunities for the growth of the genome sequencing market in the near future.
This genome sequencing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the genome sequencing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Genome Sequencing Market Scope and Market Size
The genome sequencing market is segmented on the basis of product, technology, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on the product, the genome sequencing market is segmented into consumables, systems and software, services.
- Based on the technology, the genome sequencing market is segmented into PCR, sequencing, microarray, nucleic acid extraction and purification, others.
- Based on the application, the genome sequencing market is segmented into diagnostics, drug discovery and development, precision medicine, agriculture and animal research, others.
- Based on the end user, the genome sequencing market is segmented into research centers, academic and government institutes, hospitals and clinics, pharmaceutical and biotechnology companies, others.
Genome Sequencing Market Country Level Analysis
The genome sequencing market is analysed and market size insights and trends are provided by country, product, technology, application and end user as referenced above.
The countries covered in the genome sequencing market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the genome sequencing market because of the nonstop technological advancements by the key players. Furthermore, the high investment in research and development, and the accessibility of scientifically developed of healthcare infrastructure which will boost the growth of the genome sequencing market in the region during the forecast period. Asia Pacific is projected to observe significant amount of growth in the genome sequencing market because of the calculated initiatives undertaken by the international firms to extend their occurrence because of the high customer base.
The country section of the genome sequencing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The genome sequencing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for genome sequencing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the genome sequencing market. The data is available for historic period 2010-2019.
Competitive Landscape and Genome Sequencing Market Share Analysis
The genome sequencing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to genome sequencing market.
The major players covered in the genome sequencing market report are Thermo Fisher Scientific, Illumina, Inc., QIAGEN, Eurofins Scientific, Agilent Technologies, Inc., Oxford Nanopore Technologies., F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., BGI, Danaher., General Electric Company, Eppendorf AG, Abbott, LI-COR, Inc., Siemens, PerkinElmer Inc., Macrogen Inc., DNASTAR, Geneious, Myriad Genetics, Inc., GATC Biotech, Biomatters, New England Biolabs, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Genome Sequencing Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.